ALTO Alto Ingredients, Inc.
Industrial Organic Chemicals · Nasdaq · SEC CIK 778164 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.1%
TTM net income YoY201.2%
TTM EPS YoY192.9%
Revenue 3-yr CAGR-9.1%
Net income 3-yr CAGR—
Margins
Gross margin5.8%
Operating margin2.7%
Net margin5.3%
FCF margin3.9%
EBITDA margin5.4%
Returns
ROE20.5%
ROA12.8%
ROIC (approx.)8.6%
Asset turnover2.43x
Leverage & solvency
Liabilities / assets32.1%
Debt / equity0.20x
Current ratio3.39x
Interest coverage3.16x
Cash quality & payout
Operating cash flow / net income1.08x
Accruals ratio-1.1%
Payout ratio—
Capex / revenue1.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $917.93M | $965.26M | $1.22B | $1.34B | $1.21B |
| Cost of revenue | $883.01M | $955.54M | $1.21B | $1.36B | $1.14B |
| Gross profit | $34.91M | $9.72M | $15.65M | -$27.55M | $67.78M |
| SG&A expense | $27.21M | $29.74M | $29.86M | $28.08M | $29.18M |
| Operating income | $7.36M | -$51.67M | -$23.85M | -$61.36M | $40.07M |
| Interest expense | $10.77M | $7.64M | $7.42M | $1.83M | $3.59M |
| Pretax income | $12.72M | -$58.81M | -$27.91M | -$39.67M | $47.55M |
| Income tax | -$621,000 | $173,000 | $97,000 | $1.93M | $1.47M |
| Net income | $13.34M | -$58.98M | -$28.00M | -$41.60M | $46.08M |
| EBITDA | $32.58M | -$27.27M | -$768,000 | -$36.26M | $63.36M |
| EPS (basic) | 0.16 | -0.82 | -0.40 | -0.60 | 0.62 |
| EPS (diluted) | 0.16 | -0.82 | -0.40 | -0.60 | 0.61 |
| Weighted avg. shares (diluted) | 75.66M | 73.48M | 73.34M | 71.94M | 72.22M |
| Banking | |||||
| Net interest income | — | — | -$7.42M | -$1.83M | -$3.59M |
| Balance sheet | |||||
| Cash & equivalents | $23.41M | $36.21M | $30.01M | $49.52M | $62.12M |
| Receivables | $55.07M | $58.22M | $58.73M | $68.66M | $86.89M |
| Inventory | $61.68M | $49.91M | $52.61M | $66.63M | $54.37M |
| Current assets | $155.92M | $153.12M | $168.77M | $199.12M | $229.53M |
| PP&E, net | $198.50M | $214.74M | $248.75M | $239.07M | $222.55M |
| Goodwill | — | — | — | $5.97M | — |
| Intangibles | $7.57M | $4.51M | $8.50M | $9.09M | $2.68M |
| Total assets | $388.79M | $401.44M | $454.24M | $478.32M | $484.95M |
| Current liabilities | $59.07M | $57.80M | $65.29M | $78.02M | $69.60M |
| Short-term debt | $16.60M | — | — | — | — |
| Long-term debt | $63.03M | $92.90M | $82.10M | $68.36M | $50.36M |
| Total debt | $79.63M | $92.90M | $82.10M | $68.36M | $50.36M |
| Total liabilities | $143.54M | $176.38M | $174.68M | $170.23M | $139.74M |
| Shareholders' equity | $245.24M | $225.06M | $279.56M | $308.09M | $345.21M |
| Net debt | $56.21M | $56.69M | $52.08M | $18.83M | -$11.76M |
| Shares outstanding | 77.31M | 76.57M | 75.70M | 75.15M | 72.78M |
| Cash flow statement | |||||
| Operating cash flow | $13.24M | -$3.52M | $22.02M | $6.05M | $26.82M |
| Capital expenditure | $4.60M | $11.07M | $29.53M | $37.74M | $16.38M |
| Free cash flow | $8.65M | -$14.59M | -$7.51M | -$31.70M | $10.44M |
| Investing cash flow | -$7.43M | -$13.47M | -$33.03M | -$37.66M | $27.12M |
| Financing cash flow | -$16.36M | $7.72M | $6.96M | $19.01M | -$40.00M |
| Depreciation & amortization | $25.22M | $24.41M | $23.08M | $25.09M | $23.29M |
| Stock-based compensation | $3.02M | $4.36M | $3.90M | $3.33M | $2.88M |
| Share buybacks | — | — | $3.67M | $1.32M | — |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.